Literature DB >> 22207295

Positive correlation between type 1 and 2 iodothyronine deiodinases activities in human goiters.

Valmara S Pereira1, Michelle P Marassi, Doris Rosenthal, Mário Vaisman, Vânia M Corrêa da Costa.   

Abstract

Type 1 (D1) and 2 (D2) iodothyronine deiodinases are selenocysteine-containing enzymes that catalyze the deiodination of T4 to T3 in the thyroid and in peripheral tissues. Despite their importance to the plasma T3 pool in human beings, there are few studies about their behavior in human thyroids. In order to better understand iodothyronine deiodinase regulation in the thyroid gland, we studied thyroid tissue samples from follicular adenoma (AD, n = 5), toxic diffuse goiter (TDG, n = 6), nontoxic multinodular goiter (NMG, n = 40), papillary thyroid carcinoma (PTC, n = 8), and surrounding normal tissues (NT, n = 7) from 36 patients submitted to elective thyroidectomy. D1 and D2 activities were determined by quantification of the radioiodine released by ¹²⁵I-rT3 or ¹²⁵I-T4 under standardized conditions, and expressed as pmol rT3 deiodinated per minute and mg protein (pmol rT3 min⁻¹ mg⁻¹ ptn) and fmol T4 deiodinated per minute and mg protein (fmol T4 min⁻¹ mg⁻¹ ptn), respectively. D1 activity detected in TDG and AD tissues were significantly higher than in NT, PTC or NMG samples. D2 activity was also significantly higher in TDG and AD samples than in PTC, NMG, or NT. There was great variability in D1 and D2 enzymatic activities from distinct patients as well as from different areas from the same goiter. There was a positive correlation (P < 0,0001, r = 0.4942) between D1 and D2 activities when all samples were taken into account, suggesting that-in the thyroid-these two iodothyronine deiodinases may have related regulatory mechanisms, even if conditioned by other as yet unknown factors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22207295     DOI: 10.1007/s12020-011-9587-6

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  12 in total

1.  The TNM system: our language for cancer care.

Authors:  Frederick L Greene; Leslie H Sobin
Journal:  J Surg Oncol       Date:  2002-07       Impact factor: 3.454

Review 2.  Minireview: Defining the roles of the iodothyronine deiodinases: current concepts and challenges.

Authors:  Donald L St Germain; Valerie Anne Galton; Arturo Hernandez
Journal:  Endocrinology       Date:  2009-01-29       Impact factor: 4.736

Review 3.  Thyroid carcinoma: interrelationships between local thyroid hormone metabolism by the type I 5'-deiodinase and the expression of thyroid hormone receptors and other thyroid-specific (de-)differentiation markers.

Authors:  J Köhrle
Journal:  Curr Top Pathol       Date:  1997

4.  Sexual dimorphism in thyroid function and type 1 iodothyronine deiodinase activity in pre-pubertal and adult rats.

Authors:  Michelle P Marassi; Rodrigo S Fortunato; Alba C Matos da Silva; Valmara S Pereira; Denise P Carvalho; Doris Rosenthal; Vânia M Corrêa da Costa
Journal:  J Endocrinol       Date:  2007-01       Impact factor: 4.286

5.  Expression and regulation of type II iodothyronine deiodinase in human thyroid gland.

Authors:  M Murakami; O Araki; Y Hosoi; Y Kamiya; T Morimura; T Ogiwara; H Mizuma; M Mori
Journal:  Endocrinology       Date:  2001-07       Impact factor: 4.736

6.  Effect of serum estradiol and leptin levels on thyroid function, food intake and body weight gain in female Wistar rats.

Authors:  Thiago U Pantaleão; Felippe Mousovich; Doris Rosenthal; Alvaro S Padrón; Denise P Carvalho; Vânia M Corrêa da Costa
Journal:  Steroids       Date:  2010-04-02       Impact factor: 2.668

7.  Type 2 iodothyronine deiodinase is highly expressed in human thyroid.

Authors:  D Salvatore; H Tu; J W Harney; P R Larsen
Journal:  J Clin Invest       Date:  1996-08-15       Impact factor: 14.808

Review 8.  Regulation of type 1 iodothyronine deiodinase in health and disease.

Authors:  Ronald J Koenig
Journal:  Thyroid       Date:  2005-08       Impact factor: 6.568

9.  Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases.

Authors:  Peter Laurberg; Henrik Vestergaard; Soren Nielsen; Stig E Christensen; Torben Seefeldt; Kjeld Helleberg; Klaus M Pedersen
Journal:  J Clin Endocrinol Metab       Date:  2007-03-27       Impact factor: 5.958

10.  Type I 5'-iodothyronine deiodinase activity and mRNA are remarkably reduced in renal clear cell carcinoma.

Authors:  J Pachucki; M Ambroziak; Z Tanski; J Luczak; J Nauman; A Nauman
Journal:  J Endocrinol Invest       Date:  2001-04       Impact factor: 4.256

View more
  1 in total

1.  Thyroid hormone deiodinases and cancer.

Authors:  Sabina Casula; Antonio C Bianco
Journal:  Front Endocrinol (Lausanne)       Date:  2012-06-01       Impact factor: 5.555

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.